The Chicken or the Egg: The Reciprocal Relationship Between Sleep Apnea and Heart Failure
Jan 29, 2022 12:00pm ‐ Jan 29, 2022 12:30pm
Identification: D11
Learning Objectives:
- The attendee should be able to explain the physiologic causes and differences between central and obstructive sleep apnea, as well as the prevalence of this disease process in HF patients, in order to appreciate the significance of each form as it applies to the etiology, management, and prognosis of HF in the clinical setting
- The attendee should gain a basic understanding of available screening and treatments for central and obstructive sleep apnea, including novel technologies for each, allowing them to assess their patients’ risk, recommend appropriate screening, and inform them of potential treatment options in order to improve outcomes for the HF patient.
ICD and Pacemaker Terminology: What You Need to Know in the HF Clinic
Jan 29, 2022 12:00pm ‐ Jan 29, 2022 12:30pm
Identification: D12
Learning Objectives:
- The attendee should be able to recall key device programming and reporting terms associated with the concepts of programming modes, rate response, delays, refractoriness and blanking, and use this knowledge to inform critical review of device interrogation reports in the clinic setting in order to immediately address factors which could negatively impact the HF patient or prompt referral to electrophysiology if appropriate
- The attendee should be able to recall key device programming and reporting terms associated with both ventricular and supraventricular arrhythmia detection and treatment, and use this knowledge to inform critical review of device interrogation reports in the clinic setting in order to immediately address factors which could negatively impact the HF patient or prompt referral to electrophysiology if appropriate
Medtronic Industry Presentation: HF Risk Stratification for Device Patients: Reaching More Patients with Less Resources
Jan 29, 2022 12:30pm ‐ Jan 29, 2022 1:00pm
Identification: D13
Impulse Dynamics Industry Presentation: Sharing my Experience with CCM® Therapy: Case Studies
Jan 29, 2022 12:45pm ‐ Jan 29, 2022 1:00pm
Identification: D15
Abbott Industry Presentation: Abbott Proven Device Therapies to Support Patients Along the Heart Failure Continuum
Jan 29, 2022 1:00pm ‐ Jan 29, 2022 1:15pm
Identification: D16
Three Critical Findings on the Device Check That Can Save Your HF Patient
Jan 29, 2022 1:30pm ‐ Jan 29, 2022 2:00pm
Identification: D20
Learning Objectives:
- The attendee should be able to explain the significance of key physiologic parameters beyond traditional HF measures, including heart rate histograms, pacing percentages, and arrhythmia telemetry and use these elements to critically assess the overall cardiac condition of the patient when reviewing a device interrogation in the clinic setting, to address factors which could negatively impact the HF patient
- The attendee should be able to identify potential interventions that can be immediately addressed in the clinic setting, as well as those requiring referral to electrophysiology, in order to appropriately treat pathologic findings
CHF/EF Clinic Collaboration: Working Together to Optimize Care and Improve Outcomes for HF Patients
Jan 29, 2022 1:30pm ‐ Jan 29, 2022 2:00pm
Identification: D21
Learning Objectives:
- At the end of this session, learners will be able to identify treatment strategies to improve co-morbid conditions that may worsen and accelerate HF decompensations.
- At the end of this session, learners will be able to understand how to implement a program to improve collaboration between HF and EP to optimize outcomes for HF patients.
When to Consider Transcatheter Valve Therapies for Aortic and Mitral Valve Disease
Jan 29, 2022 1:30pm ‐ Jan 29, 2022 2:30pm
Identification: D22
Learning Objectives:
- Understand the interplay between aortic and mitral valve disease and heart failure
- Differentiate between primary and secondary mitral valve regurgitation and their different treatments and outcome
- Recognize when to consider referral for transcatheter valve treatment of valve lesions - Discuss comparisons of outcome of transcatheter vs. surgical treatments
Boston Scientific Industry Presentation: HeartLogic™ Heart Failure Diagnostic: Overview and Recent Clinical Data
Jan 29, 2022 2:00pm ‐ Jan 29, 2022 2:15pm
Identification: D23
Presenter: Shawn Merhaut, MSN, ACNP-BC, CHFN, Sr. Clinical Product Manager, Boston Scientific
Description:
During this session, we will discuss the HeartLogic™ Heart Failure Diagnostic including a review of the technology and foundational data highlighting diagnostic performance. Additionally, we will focus on recently published real-world clinical data and implementation of HeartLogic into clinical practice.
Agenda:
- HeartLogic™ Technology
- Foundational Clinical Data
- Real-World Utilization and Performance
- MANAGE-HF Results